Top

Published in:

Open Access 01-06-2019 | Breast Cancer

A pilot study on aesthetic treatments performed by qualified aesthetic practitioners: efficacy on health-related quality of life in breast cancer patients

Authors: Serena Oliveri, Flavia Faccio, Silvia Pizzoli, Dario Monzani, Carolina Redaelli, Mirella Indino, Gabriella Pravettoni

Published in: Quality of Life Research | Issue 6/2019

Abstract

Purpose

Cancer treatments often produce undesirable side-effects, such as skin toxicity, impacting on everyday functioning and health-related quality of life (HRQoL). This experimental study sought to determine whether aesthetic products and treatments could significantly decrease perceived skin symptoms, psychological distress and improve skin-related QoL (SRQoL).

Methods

An experimental group composed of 100 breast patients was enrolled for specialized aesthetic treatments at the European Institute of Oncology (IEO) and compared to a control group of 70 breast patients who did not receive any aesthetic treatment. A measure of SRQoL (i.e., Skindex-16) and a distress thermometer were administered longitudinally at three time points: at baseline (T0), at 7 days from beginning of aesthetic treatment (T1) and at 28 days from beginning of aesthetic treatment (T2).

Results

Results demonstrated the efficacy of aesthetic treatment in reducing distress and improving SRQoL: while the experimental group showed significant improvements in all HRQoL areas, the control group worsened. Specifically, at T1 and T2 there were significant improvements on distress and Skindex subscales in the experimental group, with an almost complete remission of perceived symptoms at T2. Moreover, all reported cutaneous reactions significantly improved after the specialized treatments, with no differences in SRQoL in skin reaction type.

Conclusions

These findings demonstrate that aesthetic treatments for side-effects of cancer therapies can alleviate perceived distress and improve skin symptoms and HRQoL.

Available only for authorised users

Morris, A. D., Morris, R. D., Wilson, J. F., White, J., Steinberg, S., Okunieff, P., … van Dongen, J. A. (1997). Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. The Cancer Journal from Scientific American, 3(1), 6–12. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9072310.

Lee, J., Park, W., Choi, D. H., Huh, S. J., Kim, I.-R., Kang, D., & Cho, J. (2017). Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. https://doi.org/10.1007/s11136-017-1526-4.CrossRef

Güth, U., Myrick, M. E., Schötzau, A., Kilic, N., & Schmid, S. M. (2011). Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: How often and how often does it work? Breast Cancer Research and Treatment, 129(3), 799–807. https://doi.org/10.1007/s10549-011-1668-y.CrossRefPubMed

Cella, D., & Fallowfield, L. J. (2008). Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Research and Treatment, 107(2), 167–180. https://doi.org/10.1007/s10549-007-9548-1.CrossRefPubMed

Bensadoun, R.-J., Humbert, P., Krutman, J., Luger, T., Triller, R., Rougier, A., … Dreno, B. (2013). Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel. Cancer Management and Research, 5, 401–408. https://doi.org/10.2147/CMAR.S52256.CrossRefPubMedPubMedCentral

Titeca, G., Poot, F., Cassart, D., Defays, B., Pirard, D., Comas, M., … Heenen, M. (2007). Impact of cosmetic care on quality of life in breast cancer patients during chemotherapy and radiotherapy: an initial randomized controlled study. Journal of the European Academy of Dermatology and Venereology: JEADV, 21(6), 771–776. https://doi.org/10.1111/j.1468-3083.2006.02080.x.CrossRefPubMed

Williams, S. A., & Schreier, A. M. (2004). The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer. Oncology Nursing Forum, 31(1), E16–E23. https://doi.org/10.1188/04.ONF.E16-E23.CrossRefPubMed

Xiao, C., Miller, A. H., Felger, J., Mister, D., Liu, T., & Torres, M. A. (2016). A prospective study of quality of life in breast cancer patients undergoing radiation therapy. Advances in Radiation Oncology, 1(1), 10–16. https://doi.org/10.1016/j.adro.2016.01.003.CrossRefPubMedPubMedCentral

Schnur, J. B., Ouellette, S. C., Dilorenzo, T. A., Green, S., & Montgomery, G. H. (2011). A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients. Psycho-oncology, 20(3), 260–268. https://doi.org/10.1002/pon.1734.CrossRefPubMedPubMedCentral

10.

Huang, S.-M., Tai, C.-J., Lin, K.-C., Tai, C.-J., Tseng, L.-M., & Chien, L.-Y. (2013). A comparative study of symptoms and quality of life among patients with breast cancer receiving target, chemotherapy, or combined therapy. Cancer Nursing, 36(4), 317–325. https://doi.org/10.1097/NCC.0b013e318268f86d.CrossRefPubMed

11.

Hung, C.-T., Chiang, C.-P., & Wu, B.-Y. (2012). Sorafenib-induced psoriasis and hand-foot skin reaction responded dramatically to systemic narrowband ultraviolet B phototherapy. The Journal of Dermatology, 39(12), 1076–1077. https://doi.org/10.1111/j.1346-8138.2012.01615.x.CrossRefPubMed

12.

Segaert, S., & Van Cutsem, E. (2005). Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Annals of Oncology, 16(9), 1425–1433. https://doi.org/10.1093/annonc/mdi279.CrossRefPubMed

13.

Haley, A. C., Calahan, C., Gandhi, M., West, D. P., Rademaker, A., & Lacouture, M. E. (2011). Skin care management in cancer patients: An evaluation of quality of life and tolerability. Supportive Care in Cancer, 19(4), 545–554. https://doi.org/10.1007/s00520-010-0851-8.CrossRefPubMed

14.

Bolderston, A., Lloyd, N. S., Wong, R. K. S., Holden, L., Robb-Blenderman, L. & Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care (2006) The prevention and management of acute skin reactions related to radiation therapy: A systematic review and practice guideline. Supportive Care in Cancer, 14(8), 802–817. https://doi.org/10.1007/s00520-006-0063-4.CrossRefPubMed

15.

Harris, R., Probst, H., Beardmore, C., James, S., Dumbleton, C., Bolderston, A., … Southgate, E. (2012). Radiotherapy skin care: A survey of practice in the UK. Radiography, 18(1), 21–27. https://doi.org/10.1016/j.radi.2011.10.040.CrossRef

16.

Kumar, S., Juresic, E., Barton, M., & Shafiq, J. (2010). Management of skin toxicity during radiation therapy: A review of the evidence. Journal of Medical Imaging and Radiation Oncology, 54(3), 264–279. https://doi.org/10.1111/j.1754-9485.2010.02170.x.CrossRefPubMed

17.

Ulff, E., Maroti, M., Serup, J., & Falkmer, U. (2013). A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams. Radiotherapy and Oncology, 108(2), 287–292. https://doi.org/10.1016/j.radonc.2013.05.033.CrossRefPubMed

18.

Kirova, Y. M., Fromantin, I., De Rycke, Y., Fourquet, A., Morvan, E., Padiglione, S., … Bollet, M. A. (2011). Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. Radiotherapy and Oncology, 100(2), 205–209. https://doi.org/10.1016/j.radonc.2011.05.014.CrossRefPubMed

19.

Kodiyan, J., & Amber, K. (2015). A review of the use of topical calendula in the prevention and treatment of radiotherapy-induced skin reactions. Antioxidants, 4(2), 293–303. https://doi.org/10.3390/antiox4020293.CrossRefPubMedPubMedCentral

20.

McQuestion, M. (2006). Evidence-based skin care management in radiation therapy. Seminars in Oncology Nursing, 22(3), 163–173. https://doi.org/10.1016/j.soncn.2006.04.004.CrossRefPubMed

21.

Falkensteiner, M., Mantovan, F., Müller, I., & Them, C. (2011). The use of massage therapy for reducing pain, anxiety, and depression in oncological palliative care patients: A narrative review of the literature. ISRN Nursing. https://doi.org/10.5402/2011/929868.CrossRefPubMedPubMedCentral

22.

Collinge, W., MacDonald, G., & Walton, T. (2012). Massage in supportive cancer care. Seminars in Oncology Nursing, 28(1), 45–54. https://doi.org/10.1016/j.soncn.2011.11.005.CrossRefPubMed

23.

Drackley, N. L., Degnim, A. C., Jakub, J. W., Cutshall, S. M., Thomley, B. S., Brodt, J. K., … Boughey, J. C. (2012). Effect of massage therapy for postsurgical mastectomy recipients. Clinical Journal of Oncology Nursing, 16(2), 121–124. https://doi.org/10.1188/12.CJON.121-124.CrossRefPubMed

24.

Karagozoglu, S., & Kahve, E. (2013). Effects of back massage on chemotherapy-related fatigue and anxiety: Supportive care and therapeutic touch in cancer nursing. Applied Nursing Research, 26(4), 210–217. https://doi.org/10.1016/j.apnr.2013.07.002.CrossRefPubMed

25.

Keir, S. T., & Saling, J. R. (2012). Pilot study of the impact of massage therapy on sources and levels of distress in brain tumour patients. BMJ Supportive and Palliative Care, 2(4), 363–366. https://doi.org/10.1136/bmjspcare-2012-000224.CrossRefPubMed

26.

Somani, S., Merchant, S., & Lalani, S. (2013). A literature review about effectiveness of massage therapy for cancer pain. JPMA. The Journal of The Pakistan Medical Association, 63(11), 1418–1421.PubMed

27.

Nozawa, K., Shimizu, C., Kakimoto, M., Mizota, Y., Yamamoto, S., Takahashi, Y., Fujiwara, Y. (2013). Quantitative assessment of appearance changes and related distress in cancer patients. Psycho-Oncology, 22(9), 2140–2147. https://doi.org/10.1002/pon.3268.CrossRefPubMed

28.

CTCAE, C. T. C. for A. E. (2010). Common terminology criteria for adverse events (CTCAE). Publish (vol. 2009).

29.

Cox, J. D., Stetz, J., & Pajak, T. F. (1995). Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). International Journal of Radiation Oncology*Biology*Physics, 31(5), 1341–1346. https://doi.org/10.1016/0360-3016(95)00060-C.CrossRef

30.

Perugini, M., Gallucci, M., & Costantini, G. (2018). A practical primer to power analysis for simple experimental designs. International Review of Social Psychology. https://doi.org/10.5334/irsp.181.CrossRef

31.

Chren, M.-M. (2012). The Skindex instruments to measure the effects of skin disease on quality of life. Dermatologic Clinics, 30(2), 231–236. https://doi.org/10.1016/j.det.2011.11.003.CrossRefPubMed

32.

Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., … Schrag, D. (2006). Patient versus clinician symptom reporting using the National Cancer institute common terminology criteria for adverse events: Results of a questionnaire-based study. Lancet Oncology, 7(11), 903–909. https://doi.org/10.1016/S1470-2045(06)70910-X.CrossRefPubMed

33.

Chren, M.-M., Lasek, R. J., Sahay, A. P., & Sands, L. P. (2001). Measurement properties of Skindex-16: A Brief quality-of-life measure for patients with skin diseases. Journal of Cutaneous Medicine and Surgery, 5(2), 105–110. https://doi.org/10.1177/120347540100500202.CrossRefPubMed

34.

Mitchell, A. J., Baker-Glenn, E. A., Granger, L., & Symonds, P. (2010). Can the distress thermometer be improved by additional mood domains? part i. initial validation of the emotion thermometers tool. Psycho-Oncology. https://doi.org/10.1002/pon.1523.CrossRefPubMedPubMedCentral

35.

Cutillo, A., O’Hea, E., Person, S., Lessard, D., Harralson, T., & Boudreaux, E. (2017). The distress thermometer: Cutoff points and clinical use. Oncology Nursing Forum. https://doi.org/10.1188/17.ONF.329-336.CrossRefPubMedPubMedCentral

36.

Male, D. A., Fergus, K. D., & Cullen, K. (2016). Sexual identity after breast cancer: Sexuality, body image, and relationship repercussions. Current Opinion in Supportive and Palliative Care, 10(1), 66–74. https://doi.org/10.1097/SPC.0000000000000184.CrossRefPubMed

37.

Paterson, C. L., Lengacher, C. A., Donovan, K. A., Kip, K. E., & Tofthagen, C. S. (2015). Body image in younger breast cancer survivors: A systematic review. Cancer Nursing, 39(1), 39–58. https://doi.org/10.1097/NCC.0000000000000251.CrossRef

38.

Knobf, T. M., & Sun, Y. (2005). A longitudinal study of symptoms and self-care activities in women treated with primary radiotherapy for breast cancer. Cancer Nursing, 28(3), 210–218.CrossRef

39.

Sundaresan, P., Sullivan, L., Pendlebury, S., Kirby, A., Rodger, A., Joseph, D., … Stockler, M. R. (2015). Patients’ perceptions of health-related quality of life during and after adjuvant radiotherapy for T1N0M0 breast cancer. Clinical Oncology, 27(1), 9–15. https://doi.org/10.1016/j.clon.2014.09.007.CrossRefPubMed

40.

Montazeri, A. (2008). Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007. Journal of Experimental and Clinical Cancer Research: CR, 27(1), 32. https://doi.org/10.1186/1756-9966-27-32.CrossRefPubMed

41.

Quintard, B., & Lakdja, F. (2008). Assessing the effect of beauty treatments on psychological distress, body image, and coping: A longitudinal study of patients undergoing surgical procedures for breast cancer. Psycho-Oncology, 17(10), 1032–1038. https://doi.org/10.1002/pon.1321.CrossRefPubMed

42.

Fabbrocini, G., Cameli, N., Romano, M., Mariano, M., Panariello, L., Bianca, D., & Monfrecola, G. (2012). Chemotherapy and skin reactions. Journal of Experimental and Clinical Cancer Research, 31(1), 50. https://doi.org/10.1186/1756-9966-31-50.CrossRefPubMed

43.

Balagula, Y., Lacouture, M. E., & Cotliar, J. a. (2010). Dermatologic toxicities of targeted anticancer therapies. The Journal of Supportive Oncology, 8, 149–161.CrossRef

44.

Alley, E., Green, R., & Schuchter, L. (2002). Cutaneous toxicities of cancer therapy. Current Opinion in Oncology, 14(2), 212–216. https://doi.org/10.1097/00001622-200203000-00012.CrossRefPubMed

45.

Saif, M. W. (2011). Capecitabine and hand-foot syndrome. Expert opinion on drug safety, 10(2), 159–169. https://doi.org/10.1517/14740338.2011.546342.CrossRefPubMed

Title: A pilot study on aesthetic treatments performed by qualified aesthetic practitioners: efficacy on health-related quality of life in breast cancer patients
Authors: Serena Oliveri
Flavia Faccio
Silvia Pizzoli
Dario Monzani
Carolina Redaelli
Mirella Indino
Gabriella Pravettoni
Publication date: 01-06-2019
Publisher: Springer International Publishing
Keywords: Breast Cancer
Breast Cancer
Published in: Quality of Life Research / Issue 6/2019
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02133-9

At a glance: The STEP trials

Springer Medicine

A pilot study on aesthetic treatments performed by qualified aesthetic practitioners: efficacy on health-related quality of life in breast cancer patients

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2019

Health-related quality of life among children, adolescents, and adults with bladder exstrophy–epispadias complex: a systematic review of the literature and recommendations for future research

The effects of clinical illness severity and physical activity on health-related quality of life in schizophrenia

Advancing the use of patient-reported outcomes in practice: understanding challenges, opportunities, and the potential of health information technology

Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis

Diversity in changes of HRQoL over a 1-year period after radiotherapy in Norwegian breast cancer patients: results of cluster analyses

Development and validation of the caregiver roles and responsibilities scale in cancer caregivers